Trade AstraZeneca ^AZN

7,854 Shares in Astrazeneca Plc $AZN Bought by Hamel Associates Inc. - Markets Daily

Dorsey & Whitney Trust CO LLC Has $3.94 Million Stake in Astrazeneca Plc $AZN - Stock Observer

AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer - The Economic Times

Type 2 Diabetes breakthrough: No more a jab - AstraZeneca's new oral GLP-1 delivers up to 10.5% weight loss

Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

Opinion - Big Pharma lost in court - Congress must not bail it out

Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon

Jim Cramer on AstraZeneca: "On Track to Hit the Ambitious Long-Term Financial Targets"

WINTON GROUP Ltd Invests $965,000 in Astrazeneca Plc $AZN - Daily Political

Is It Too Late To Reassess AstraZeneca (LSE:AZN) After Its Strong Multi‑Year Run?

"Brexit into Asia": British Capital's Shift Towards China

Encouraging trial results for AstraZeneca's new weight-loss pill - Japan Today

Astrazeneca (NYSE:AZN) Given "Buy" Rating at Jefferies Financial Group - Markets Daily

ADA: AZ's oral GLP-1 shows 'competitive efficacy' in phase 2

Jefferies Financial Group Reaffirms "Buy" Rating for AstraZeneca (LON:AZN) - Markets Daily

Deutsche Bank Aktiengesellschaft Reiterates "Sell" Rating for Astrazeneca (NYSE:AZN) - Stock Observer

GSK (GSK) Stock Slides 3% Following $10.6B Nuvalent Acquisition Deal

AstraZeneca's New Oral GLP-1 Aids Weight Loss and Lowers Blood Sugar - AOL

6,250 Shares in AstraZeneca PLC $AZNCF Acquired by Monetary Management Group Inc. - Daily Political

AstraZeneca's Elecoglipron Pill: Shattering Weight Loss Records with 10.5% Reduction, ETPharma

AstraZeneca's Obesity Pill Helps Patients Lose Weight in Midstage Trials | Morningstar

Ionis Appoints Hantson As Board Of Director, Effective Immediately

Quantum Corp (QMCO) Faces Pre-Market Decline of 3.1%

Geode Capital Management LLC Sells 17,227 Shares of Astrazeneca Plc $AZN - Stock Observer

Erste Asset Management GmbH Reduces Stock Position in Astrazeneca Plc $AZN - Stock Observer

O Shaughnessy Asset Management LLC Increases Stock Holdings in Astrazeneca Plc $AZN - Daily Political

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

The European respiratory society guideline for adult bronchiectasis 2025: summary and implementation guide for primary care

Sun Pharmaceutical Industries Ltd Option Chain & Strike Prices | IIFL Capital

Sun Pharmaceutical Industries Ltd Futures Share Price & Chart Today | IIFL Capital

First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial

2 FTSE shares for beginners starting an ISA

Capital International Investors Has $2.55 Billion Stock Holdings in Astrazeneca Plc $AZN - Stock Observer

OneAscent Family Office LLC Makes New $613,000 Investment in Astrazeneca Plc $AZN - Stock Observer

Astrazeneca Plc $AZN Shares Purchased by Cibc World Market Inc. - Daily Political

AstraZeneca CEO says AI is reshaping drug development - and helping boost the odds of success

Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its 30.8% One-Year Surge?

AstraZeneca (AZN) Stock: Bernstein Identifies 37% Upside Potential in Overlooked Segment

Diamond Blackfan Anemia Market Unlocking New Revenue Opportunities and Strategic Expansion by 2036 - DelveInsight | Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA

AstraZeneca PLC (AZN) Shares Surge 3.1% -- What GF Score of 83 T

AstraZeneca (AZN) Engages with FDA Leadership on Rare Disease Initiatives

Low-dose Zoladex won't be available in Australia from November. What might that mean for you?

Other news to note for June 4, 2026 | BioWorld

GKV Capital Management Co. Inc. Takes $1.58 Million Position in Astrazeneca Plc $AZN - Daily Political

A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms

Influence of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on the management of blood pressure in Japanese patients with diabetes

AZN: Recent Drug Approvals And Key Readouts Will Support Bullish Repricing

AstraZeneca CEO: AI is affecting every part of our company

3 UK shares to consider holding in a Stocks and Shares ISA for a decade

SCS Capital Management LLC Reduces Position in Astrazeneca Plc $AZN - Stock Observer

Martin Investment Management LLC Has $54.32 Million Stock Position in Astrazeneca Plc $AZN - Stock Observer

Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions

Norges Bank Makes New Investment in Astrazeneca Plc $AZN - Stock Observer

Northwestern Mutual Wealth Management Co. Has $15.13 Million Stock Position in Astrazeneca Plc $AZN - Stock Observer

AstraZeneca (AZN) Benefits from New FDA Guidance on Gene Therapy Development

AstraZeneca (AZN) Reports Promising Phase III Trial Results for Camizestrant

AstraZeneca's (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point

ANCA Vasculitis Market to Witness Transformational Growth Opportunities by 2036 - DelveInsight | CSL, Amgen, NS Pharma, Amgen, GlaxoSmithKline, AstraZeneca, Chemocentry, Staidson (Beijing) Biopharma

Regulatory actions for June 2, 2026 | BioWorld

ELRIG unveils keynote speakers for Drug Discovery 2026

Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohort

A homoeriodictyol sodium mouthwash reduces bitterness sensitivity in patients with gynecological cancer receiving carboplatin-based chemotherapy

Asthma Pipeline Shows Strong Momentum as 80+ Pharma Companies in the Race | DelveInsight

AstraZeneca Scores In Liver Cancer On Its Path To $40 Billion In Oncology Sales

AIM ImmunoTech (AIM) Advances Enrollment in Pancreatic Cancer Trial

AstraZeneca (AZN) Reports Positive Results in Phase III Trial for HCC Treatment

Multiple Clinical Trial Data for Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, to be Presented at ADA 2026 | Morningstar

AstraZeneca's IMFINZI-Based Regimen Cuts Progression Risk By 30% In Liver Cancer Trial

Assessing McCormick (MKC) Valuation After Cindy Hoots Joins The Board Of Directors

Astrazeneca's (AZN) "Buy" Rating Reiterated at Barclays - Daily Political

Regulatory actions for June 1, 2026 | BioWorld

SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial

Citi Keeps Their Buy Rating on AstraZeneca (AZN)

Legal & General Group Plc Trims Stock Holdings in Astrazeneca Plc $AZN - Daily Political

Cambridge duo Arm and AstraZeneca rewrite corporate history

AstraZeneca (AZN) Gains Approval for Imfinzi in Bladder Cancer Treatment

25,037 Shares in Astrazeneca Plc $AZN Purchased by SBI Okasan Asset Management Co.Ltd. - Stock Observer

Thoroughbred Financial Services LLC Makes New $1.49 Million Investment in AstraZeneca PLC $AZNCF - Stock Observer

CelLBxHealth signs master services agreement with AstraZeneca

AZN Gains FDA Approval for New Bladder Cancer Treatment

Texas Capital Bank Wealth Management Services Inc Acquires Shares of 3,416 Astrazeneca Plc $AZN - Daily Political

What McCormick (MKC)'s Move to Add a Digital and AI Strategist to Its Board Means for Shareholders - Simply Wall St News

AstraZeneca's durvalumab approved in U.S. for NMIBC patients

AstraZeneca, Roche to boost digital pathology uptake in APAC and more briefs

IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer

Simple Blood Count May Help Predict Flare-Up Risk in Asthma | MDedge

Sun Pharmaceuticals Industries Ltd Futures Share Price & Chart Today | IIFL Capital

Preoperative onapristone-XR in postmenopausal women with progesterone receptor-positive (PgR+)/HER2-negative early breast cancer: SOLTI-1802 ONAWA trial results

AstraZeneca (AZN) Receives FDA Approval for Imfinzi in Bladder Cancer Treatment

AstraZeneca (AZN) Gains FDA Approval for Imfinzi in Bladder Cancer Treatment

AstraZeneca (AZN) Secures U.S. Approval for Imfinzi Combination Therapy

AstraZeneca: Oncology and Rare Disease Data at ASCO 2026

Cary Street Partners Financial LLC Makes New Investment in AstraZeneca PLC $AZNCF - Zolmax

Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy

AZN's Patent Granted in Canada Strengthens Position in Male Infertility Treatment

FDA delays ruling on AstraZeneca drug after negative adcomm vote

William Blair Investment Management LLC Raises Stake in Astrazeneca Plc $AZN - Stock Observer